NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Oshea Herbals Aims for Rs 650 Crore in Sales Over Next Three Years

Kolkata-based personal care company Oshea Herbals, which began with 15 products in 2010, is targeting Rs 650 crore worth of products in sales over the next three years. This ambitious goal is backed by a widening retail network and a push into new product categories.

Founded by Jeetendra Kundlia, the company has grown to over 600 stock-keeping units (SKUs) and has a distribution presence across 20,000-plus retail outlets, with cumulative sales of Rs 210 crore worth of products. The company expanded its operations from eastern India into Uttar Pradesh and Maharashtra, gradually adding new markets rather than simultaneously.

Before founding Oshea, Kundlia spent years as a super stockist for more than 18 personal care brands. This experience shaped two core convictions: quality products were priced out of regular use, and affordable ones rarely held consistency. The company was built to address both of these issues.

Read also: FirstClub Secures $55 Million in Funding from Peak XV, Sofina, and Other Investors 9 Months After $22 Million Series A Round

The company's early growth was deliberately slow. The portfolio remained at 15 products for nearly three years while the company tested acceptance at the retail level. Products that moved well stayed in the portfolio, while those that didn't were reworked. The 600-plus SKU range was built up from there.

A focus on papaya-based formulations gave the brand a clear identity in skincare, targeting pigmentation and uneven tone — concerns prevalent across a wide consumer base. In 2022, the company commissioned an AHU-based manufacturing facility following a $6 million fundraise from First Bridge Capital, bringing roughly 90 percent of production in-house. The business has remained EBITDA positive.

The company is now transitioning to the next generation, with Yash Kundlia and Vaibhav Kundlia driving a sharper focus on digital channels and brand visibility. Actor Nushrratt Bharuccha has been brought on as brand ambassador, aimed at consumers in the 30-45 age group.

Oshea Herbals is also exploring new category bets, including suncare, derma-led products, salon ranges, fragrances, and colour cosmetics. Online growth is being managed carefully, with the company flagging pricing pressure from marketplace discounting as a known risk.

Read also: RBI Policy Preview: A Cautionary Wait Ahead

YearSales (Rs crore)
20100 (launched)
Cumulative210
Target (next 3 years)650

Note: The table shows the company's sales growth over the years, including the target for the next three years.

Investor Takeaway

Investors should consider the growth potential of Oshea Herbals as it expands its product offerings and retail network.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.